ETF Holdings Breakdown of 600161.SS

Stock NameBTBP (Beijing Tiantan Biological Products Corporation Limited) (天坛生物)
Ticker600161.SS(CNY) Shanghai Stock Exchange
TYPEEquity
CountryChina

600161.SS institutional holdings

The following institutional investment holdings of 600161.SS have been identified

Date ETF ISIN/Name Num Shares Book value
2025-03-11 IE00BKM4GZ66 (iShares Core MSCI Emerging Markets IMI UCITS) 154,820CNY 426,254 1.2%
2025-03-11 IE00BD45KH83 (iShares Core MSCI EM IMI UCITS ETF USD (Dist) GBP) 154,820CNY 426,254 1.2%
2025-03-11 IE00B0M63177 (iShares MSCI EM UCITS ETF USD (Dist) USD) 43,620CNY 120,095
2025-03-11 IE00BFNM3N12 (iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist) GBP) 91,220CNY 251,149 1.2%
2025-03-11 IE00BFNM3P36 (iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc) GBP) 91,220CNY 251,149
2025-03-11 IE00BQT3WG13 (iShares MSCI China A UCITS USD) 911,260 -2.4%CNY 2,508,899 -1.1%
2025-03-11 IE00099GAJC6 (ISHETFCNYEIMETFP) 911,260 -2.4%CNY 2,508,899 -1.1%
2025-03-11 IE00BJ5JPG56 (iShares MSCI China UCITS ETF USD Acc) 189,480CNY 521,680
2025-03-11 IE00BL977C92 (iShares MSCI China UCITS ETF) 189,480 1.1%CNY 521,680 2.3%
2025-03-11 IE00B8KGV557 (iShares Edge MSCI EM Minimum Volatility UCITS ETF USD (Acc)) 84,320CNY 232,152 1.2%
2025-03-11 IE00BHZPJ239 (iShares MSCI EM ESG Enhanced UCITS ETF USD Acc) 39,400CNY 108,477
2025-03-11 IE00BHZPJ122 (iShares MSCI EM ESG Enhanced UCITS ETF USD Inc GBP) 39,400CNY 108,477 1.2%
Total =2,900,300 CNY 7,985,165
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.